Ibrahim El-Haffaf

An Update on Population Pharmacokinetic Analyses of Vancomycin, Part II: In Pediatric Patients

F. Nekka, A. Marsot, Abdullah Aljutayli, 2021, Clinical Pharmacokinetics.

Piperacillin-Tazobactam in Intensive Care Units: A Review of Population Pharmacokinetic Analyses

A. Marsot, Ibrahim El-Haffaf, Jean-Alexandre Caissy, 2021, Clinical Pharmacokinetics.

Using a Validated Population Pharmacokinetic Model for Dosing Recommendations of Continuous Infusion Piperacillin for Critically Ill Adult Patients

L. Velly, R. Guilhaumou, A. Marsot, 2022, Clinical Pharmacokinetics.

Impact of piperacillin unbound fraction variability on dosing recommendations in critically ill patients

L. Velly, R. Guilhaumou, A. Marsot, 2022, British journal of clinical pharmacology.

Towards model-informed precision dosing of piperacillin: multicenter systematic external evaluation of pharmacokinetic models in critically ill adults with a focus on Bayesian forecasting

S. Wicha, J. Zander, S. Hagel, 2023, Intensive Care Medicine.

Exposure levels and target attainment of piperacillin/tazobactam in adult patients admitted to the intensive care unit: a prospective observational study.

A. Marsot, Ibrahim El-Haffaf, Martin Albert, 2024, Canadian journal of anaesthesia = Journal canadien d'anesthesie.